Italy· 038119032
RAMIPRIL IDROCLOROTIAZIDE*14 cpr 5 mg + 25 mg
A medicinal product containing ramipril/idroclorotiazide, registered in Italy by SANDOZ SpA, on the national reimbursement list.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Active substance
- Ramipril/idroclorotiazide
- Manufacturer
- SANDOZ SpA
- Country
- Italy (IT)
- ATC code
- —
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic038119032RAMIPRIL IDROCLOROTIAZIDE*14 cpr 5 mg + 25 mgEUR 2.38
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d5d3f027-fb78-4a64-b588-92c3810dbbd0 GET /v1/drugs/d5d3f027-fb78-4a64-b588-92c3810dbbd0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 2.38,
"source": "aifa",
"currency": "EUR",
"strength": "RAMIPRIL+IDROCLOROTIAZIDE 5+25MG 14 UNITA' USO ORALE",
"substance": "Ramipril/idroclorotiazide",
"equivalence_group": "DSB",
"transparency_flag": "X"
}See everything about ramipril/idroclorotiazide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.